The FDC battel continues

The NewDelhi government has moved the Supreme Court in defense of the ban it imposed earlier this year on hundreds of fixed dose combination drugs that it alleged to be irrational, unsafe for patients and lacking scientific validation. Armed with approvals from state regulatory agencies and, in certain cases, the central drug regulator, scores of drug makers countered the decision in courts. Read more here.

Drugs<>Therapeutics<>Big Pharma
impas Natesh Prabhu Administrator & Chief Editor | Clinical Pharmacologist | Diabetic-Sexual Medicine-Regenerative Therapy Consultant | President, Indian Medical Pharmacologists Association
0

Leave a Reply

↓